Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2003
09/03/2003CN1440287A Method of treating peripheral vascular diseases, peripheral neuropathies, and automatic neuropathies
09/03/2003CN1440278A Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethy lene) cytidine
09/03/2003CN1439424A Anti-SARS virus transfer factor preparation method
09/03/2003CN1439410A Extraction method for antibiosis antiviral active placement from honeysuckle
09/03/2003CN1439404A Disinfectant bactericidal Chinese medicine preparation and producing process thereof
09/03/2003CN1439398A Naris feeding medicine against scrofula
09/03/2003CN1439380A Degradable apisin microballoons injection and preparation thereof
09/03/2003CN1439373A Oral preparation of mehanesulfonae pezusacine and its preparing process-antiinfection
09/03/2003CN1439371A Matrine sustained releasing agent and its preparing process
09/03/2003CN1120238C Pure herpes virus recombined with visco-particle as basement and its use
09/03/2003CN1120004C Coated gongyanping tablet in special shape and its making process
09/02/2003US6613926 Perchloramido phosphonyl reagents and analogs thereof
09/02/2003US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/02/2003US6613911 Reaction of haloarylacetic acids or esters with olefins to give vinylarylacetic acids or esters, oxidation with an oxidizing reagent gives formylarylacetic acids or esters
09/02/2003US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines
09/02/2003US6613874 Melanocortin receptor ligands
09/02/2003US6613807 Linking low molecular weight drugs containing a carboxylic acid group and an amine, thiol, alcohol or phenol, which is released when hydrolysis occurs
09/02/2003US6613799 Complex having excellent antibacterial activity and anticancer activity
09/02/2003US6613788 Transdermal patch to systemically deliver effective dose of histamine comprising histamine and controlled release preparation which releases drug over period of time sufficient to obtain stable elevated levels in circulating blood
09/02/2003US6613787 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer
09/02/2003US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors
09/02/2003US6613775 Imidazo[1,2-a]pyridine compounds
09/02/2003US6613764 Aspartic protease inhibitors
09/02/2003US6613747 6-O-carbamoyl ketolide antibacterials
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
09/02/2003US6613742 Chemokine-derived synthetic peptides
09/02/2003US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine
09/02/2003US6613556 Infecting cells from a continuous epithelial or fibroblast cell line, free of contaminants, with a high titer growth strain of dengue virus; use in vaccine production
09/02/2003US6613354 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
09/02/2003US6613349 Bactericides
09/02/2003US6613333 Immunodominant human T-cell epitopes of hepatitis C virus
09/02/2003US6613322 Administering enzyme inhibitors
08/2003
08/28/2003WO2003070987A1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence
08/28/2003WO2003070981A2 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
08/28/2003WO2003070976A2 Methods for determining the influence of protein binding on antiretroviral activity
08/28/2003WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
08/28/2003WO2003070969A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070921A1 METHODS FOR PRODUCING Ϝδ T CELLS
08/28/2003WO2003070919A1 Antimicrobial composition
08/28/2003WO2003070918A2 Rna interference by modified short interfering nucleic acid
08/28/2003WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)
08/28/2003WO2003070905A2 Electroporation methods for introducing bioactive agents into cells
08/28/2003WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070897A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid
08/28/2003WO2003070883A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
08/28/2003WO2003070772A1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments
08/28/2003WO2003070764A1 Method for producing interferon
08/28/2003WO2003070762A1 Compositions isolated from bovine mammary gland and methods for their use
08/28/2003WO2003070761A1 Dual-effect ligands comprising anti-inflammatory hsp peptide epitopes for immunomodulation
08/28/2003WO2003070755A2 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier
08/28/2003WO2003070754A1 Histone deacetylase inhibitors and process for producing the same
08/28/2003WO2003070751A2 Partial peptide mimetics and methods
08/28/2003WO2003070750A2 Rna interference mediated inhibition of hepatitis c virus
08/28/2003WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070726A1 Pyranones useful as atm inhibitors
08/28/2003WO2003070715A1 An antimicrobial agent
08/28/2003WO2003070711A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
08/28/2003WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003WO2003070682A1 NON-COVALENT INHIBITORS OF AmpC ß-LACTAMASE
08/28/2003WO2003070274A1 The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
08/28/2003WO2003070270A1 Strategy for retroviral immunotherapy
08/28/2003WO2003070268A1 Remedy for infections
08/28/2003WO2003070262A1 Pharmacological composition based on biologically active substances obtained from tribulus terrestris l
08/28/2003WO2003070256A1 Hyaluronic acid mediated adenoviral transduction
08/28/2003WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003WO2003070239A1 Benzylidene thiazolidinediones and their use as antimycotic agents
08/28/2003WO2003070238A1 Thiazolidine antifungal agents
08/28/2003WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003WO2003070231A1 Antibacterial compositions
08/28/2003WO2003070220A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
08/28/2003WO2003070219A1 Drug delivery system for the subconjunctival administration of fine grains
08/28/2003WO2003070218A1 Sustained-release ointment for topical administration
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070193A2 RNA INTERFERENCE MEDIATED INHIBITION OF HIV GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070180A2 Compositions and methods for delivery of skin cosmeceuticals
08/28/2003WO2003070171A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003WO2003069997A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003037384A3 Polymer conjugates of protein kinase c inhibitors
08/28/2003WO2003031449A3 Cross-linked glycopeptide-cephalosporin antibiotics
08/28/2003WO2003030931A3 Vaccine against arthropod-borne infectious diseases
08/28/2003WO2003029289A3 Fragements of heat shock proteins and their use
08/28/2003WO2003025018A3 Dimeric and multimeric antigen binding structure
08/28/2003WO2003014153A3 Cellular virus receptors and methods of use.
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003006017A3 Use of certain castanospermine esters in the treatment of influenza virus infections
08/28/2003WO2003005957A3 Mutants of clostridium septicum alpha toxin and vaccines, antibodies, sera, and methods of treatment therewith
08/28/2003WO2003000738A3 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate
08/28/2003WO2002097051A3 Protein arrays and methods and systems for producing the same
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002092818A3 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
08/28/2003WO2002088328A3 Method for generating highly active human dendritic cells from monocytes
08/28/2003WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
1 ... 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 ... 1798